Because drug manufacturers set list prices for the entire U.S. market, these policy changes will be felt beyond Medicare. The Congressional Budget Office (CBO) expects manufacturers to reduce...
To examine whether the IRA has had immediate impacts on drug development,we review R&D-related developments discussed in earnings releases for the firsttwo quarters of 2023...
Among other things, Medicare gained an entirely new authority—to negotiate what it pays for certain older, branded pharmaceutical products. The policy will take effect on a fast timeline:...
Cathy McMorris Rodgers (R-WA) and her Republican colleagues claim the Protecting Health Care for All Patients Act of 2023 legislation, which would ban the government from assessing whether...
Much has been written about the act’s individual provisions, but little has been said about how they fit together as a whole. In fact, these seemingly standalone reforms...
Partner with Verdant for rigorous, objective economic analysis.